Pieris Cash Ratio from 2010 to 2024

PIRS Stock  USD 15.93  0.08  0.50%   
Pieris Pharmaceuticals Cash Ratio yearly trend continues to be comparatively stable with very little volatility. Cash Ratio will likely drop to 1.39 in 2024. From the period from 2010 to 2024, Pieris Pharmaceuticals Cash Ratio quarterly data regression had r-value of (0.08) and coefficient of variation of  102.05. View All Fundamentals
 
Cash Ratio  
First Reported
2010-12-31
Previous Quarter
1.45915115
Current Value
1.39
Quarterly Volatility
2.54789969
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pieris Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pieris Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 12.3 M or Selling General Administrative of 13.5 M, as well as many indicators such as Price To Sales Ratio of 0.36, Dividend Yield of 0.0 or PTB Ratio of 0.58. Pieris financial statements analysis is a perfect complement when working with Pieris Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Pieris Pharmaceuticals Correlation against competitors.
For more information on how to buy Pieris Stock please use our How to Invest in Pieris Pharmaceuticals guide.

Latest Pieris Pharmaceuticals' Cash Ratio Growth Pattern

Below is the plot of the Cash Ratio of Pieris Pharmaceuticals over the last few years. It is Pieris Pharmaceuticals' Cash Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pieris Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Cash Ratio10 Years Trend
Very volatile
   Cash Ratio   
       Timeline  

Pieris Cash Ratio Regression Statistics

Arithmetic Mean2.50
Geometric Mean1.79
Coefficient Of Variation102.05
Mean Deviation1.65
Median1.56
Standard Deviation2.55
Sample Variance6.49
Range9.8059
R-Value(0.08)
Mean Square Error6.95
R-Squared0.01
Significance0.79
Slope(0.04)
Total Sum of Squares90.89

Pieris Cash Ratio History

2024 1.39
2023 1.46
2022 1.06
2021 2.33
2020 3.18
2019 2.31
2018 1.56

About Pieris Pharmaceuticals Financial Statements

Pieris Pharmaceuticals shareholders use historical fundamental indicators, such as Cash Ratio, to determine how well the company is positioned to perform in the future. Although Pieris Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Pieris Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pieris Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Ratio 1.46  1.39 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pieris Stock Analysis

When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.